|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2001-12-13
|
|
pubmed:abstractText |
Docetaxel (Taxotere) has demonstrated high antitumour activity in first- and second-line treatment of metastatic breast cancer. This study analysed the efficacy and toxicity of docetaxel given weekly.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1393-8
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11762809-Adult,
pubmed-meshheading:11762809-Aged,
pubmed-meshheading:11762809-Alopecia,
pubmed-meshheading:11762809-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:11762809-Breast Neoplasms,
pubmed-meshheading:11762809-Disease-Free Survival,
pubmed-meshheading:11762809-Female,
pubmed-meshheading:11762809-Humans,
pubmed-meshheading:11762809-Infusions, Intravenous,
pubmed-meshheading:11762809-Male,
pubmed-meshheading:11762809-Middle Aged,
pubmed-meshheading:11762809-Neoplasm Metastasis,
pubmed-meshheading:11762809-Neutropenia,
pubmed-meshheading:11762809-Paclitaxel,
pubmed-meshheading:11762809-Taxoids,
pubmed-meshheading:11762809-Treatment Outcome
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Weekly docetaxel (Taxotere) in patients with metastatic breast cancer.
|
|
pubmed:affiliation |
Department of Internal Medicine III Klinikum Grosshadern, University of Munich Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
